Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 5, 1999, Pages 275-279

  Sica, Gabriel ^a   Chen, Lieping ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Costimulation; T cell activation; Tumor; Tumor necrosis factor receptor

Indexed keywords

CD137 ANTIGEN; CD28 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOCYTE ANTIGEN; LIGAND; NERVE GROWTH FACTOR RECEPTOR; OKT 3; TNFRSF9 PROTEIN, HUMAN; TNFRSF9 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EXPERIMENTAL NEOPLASM; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MOUSE; MULTIGENE FAMILY; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; ANTIGENS, CD28; CYTOTOXICITY, IMMUNOLOGIC; GENE THERAPY; HUMANS; IMMUNOTHERAPY; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MULTIGENE FAMILY; MUROMONAB-CD3; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0033253965     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ALDERSON M. R., SMITH C. A., TOUGH T. W., DAVIS-SMITH T., ARMITAGE R. J., FALK B., Roux E., BAKER E., SUTHERLAND G. R. and DIN W. S. (1994): Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol., 24, 2219-2227.
2. ARCH R. H. and THOMPSON C. B. (1998): 4-1BB and OX40 are members of a tumor necrosis factor (TNF) -nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappa B. Mol. Cell. Biol., 18, 558-565.
3. CHALUPNY N. J., PEACH R., HOLLENBAUGH D., LEDBETTER J. A., FARR A. G. and ARUFFO A. (1992): T-cell activation molecule 4-1BB binds to extracellular matrix proteins. Proc. Natl. Acad. Sci. USA, 89, 10360-10364.
4. CHAN A. C, DESAI D. M. and WEISS A. (1994): The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol., 12, 555-592.
5. CHEN L., ASHE S., BRADY W. A., HELLSTROM I., HELLSTROM K. E., LEDBETTER J. A., MCGOWAN P. and LINSLEY P. S. (1992): Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-1102.
6. - T cells. J. Immunol., 158, 3081-3089.
7. DEBENEDETTE M. A., CHU N. R., POLLOK K. E., HURTADO J., WADE W. F., KWON B. S. and WATTS T. H. (1995): Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J. Exp. Med., 181, 985-992.
8. - T lymphocytes by 4-1BB ligand. J. Immunol., 158, 551-559.
9. DEL PRETE G., DE CARLI M., D'ELIOS M. M., DANIEL K. C., ALMERIGOGNA F., ALDERSON M., SMITH C. A., THOMAS E. and ROMAGNANI S. (1995): CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J. Exp. Med., 182, 1655-1661.
10. hi transitional T cell in humans. Cell. Immunol., 169, 91-98.
11. + T cells with homology to tumor necrosis factor. J. Exp. Med., 180, 757-762.
12. GOODWIN R. G., DIN W. S., DAVIS-SMITH T., ANDERSON D. M., GIMPEL S. D., SATO T. A., MALISZEWSKI C. R., BRANNAN C. I., COPELAND N. G., JENKINS N. A. et al. (1993): Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol., 23, 2631-2641.
13. GRAVESTEIN L. A., BLOM B., NOLTEN L. A., DE VRIES E., VAN DER HORST G., OSSENDORP F., BORST J. and LOENEN W. A. (1993): Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family. Eur. J. Immunol., 23, 943-950.
14. HELLSTROM K. E., HELLSTROM I. and CHEN L. (1995): Can co-stimulated tumor immunity be therapeutically efficacious? Immunol. Rev., 145, 123-145.
15. HURTADO J. C., KIM S. H., POLLOK K. E., LEE Z. H. and KWON B. S. (1995): Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J. Immunol., 155, 3360-3367.
16. HURTADO J. C., KIM Y. J. and KWON B. S. (1997): Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol., 158, 2600-2609.
17. JANG I. K., LEE Z. H., KIM Y. J., KIM S. H. and KWON B. S. (1998): Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. Biochem. Biophys. Res. Commun., 242, 613-620.
18. KIM Y. J., KIM S. H., MANTEL P. and KWON B. S. (1998): Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses. Eur. J. Immunol., 28, 881-890.
19. KIM Y. J., POLLOK K. E., ZHOU Z., SHAW A., BOHLEN J. B., FRASER M. and KWON B. S. (1993): Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck1. J. Immunol., 151, 1255-1262.
20. KWON B. S., KESTLER D. P., ESHHAR Z., OH K. O. and WAKULCHIK M. (1989): Expression characteristics of two potential T cell mediator genes. Cell. Immunol., 121, 414-422.
21. KWON B. S., KOZAK C. A., KIM K. K. and PICKARD R. T. (1994): Genomic organization and chromosomal localization of the T-cell antigen 4-1BB. J. Immunol., 152, 2256-2262.
22. LANGSTEIN J., MICHEL J., FRITSCHE J., KREUTZ M., ANDREESEN R. and SCHWARZ H. (1998): CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol., 160, 2488-2494.
23. Loo D. T., CHALUPNY N. J., BAJORATH J., SHUFORD W. W., MITTLER R. S. and ARUFFO A. (1997): Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB. J. Biol. Chem., 272, 6448-6456.
24. MALLETT S., FOSSUM S. and BARCLAY A. N. (1990): Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor. EMBO. J., 9, 1063-1068.
25. MELERO I., BACH N., HELLSTROM K. E., ARUFFO A., MITTLER R. S. and CHEN L. (1998): Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur. J. Immunol., 28, 1116-1121.
26. MELERO I., JOHNSTON J. V., SHUFFORD W. W., MITTLER R. S. and CHEN L. (1998): NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol., 190, 167-172.
27. MELERO I., SHUFFORD W. W., NEWBY S. A., ARUFFO A., LEDBETTER J. A., HELLSTROM K. E., MITTLER R. S. and CHEN L. (1997): Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med., 3, 682-685.
28. MICHEL J., LANGSTEIN J., HOFSTADTER F. and SCHWARZ H. (1998): A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur. J. Immunol., 28, 290-295.
29. NAKAMURA T., LEE R. K., NAM S. Y., PODACK E. R., BOTTOMLY K. and FLAVELL R. A. (1997): Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. J. Immunol., 158, 2648-2653.
30. PINTO A., ALDINUCCI D., GLOGHINI A., ZAGONEL V., DEGAN M., PERIN V., TODESCO M., DE IULIIS A., IMPROTA S., SACCO C., GATTEI V., GRUSS H. J. and CARBONE A. (1997): The role of eosinophils in the pathobiology of Hodgkin's disease. Ann. Oncol., 8 (suppl. 2), 89-96.
31. POLLOK K. E., KIM S. H. and KWON B. S. (1995): Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4. Eur. J. Immunol., 25, 488-494.
32. POLLOK K. E., KIM Y. J., HURTADO J., ZHOU Z., KIM K. K. and KWON B. S. (1994): 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol., 24, 367-374.
33. POLLOK K. E, KIM Y. J., ZHOU Z., HURTADO J., KIM K. K., PICKARD R. T and KWON B. S. (1993): Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol., 150, 771-781.
34. SAOULLI K., LEE S. Y., CANNONS J. L., YEH W. C., SANTANA A., GOLDSTEIN M. D., BANGIA N., DE BENEDETTE M. A., MAK T. W., CHOI Y. and WATTS T. H. (1998): CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med., 187, 1849-1862.
35. SCHWARZ H., ARDEN K. and LOTZ M. (1997): CD137, a member of the tumor necrosis factor receptor family, is located on chromosome 1p36, in a cluster of related genes, and colocalizes with several malignancies. Biochem. Biophys. Res. Commun., 235, 699-703.
36. SCHWARZ H., BLANCO F. J., VON KEMPIS J., VALBRACHT J. and LOTZ M. (1996): ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood, 87, 2839-2845.
37. SETAREH M., SCHWARZ H. and LOTZ M. (1995): A mRNA variant encoding a soluble form of 4-1BB, a member of the murine NGF/TNF receptor family Gene, 164, 311-315.
38. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med., 186, 47-55.
39. ZHOU Z., POLLOK K. E., KIM K. K., KIM Y. J. and KWON B. S. (1994): Functional analysis of T-cell antigen 4-1BB in activated intestinal intra-epithelial T lymphocytes. Immunol. Lett., 41, 177-184.